Global Exenatide Market Size By Type (Extended-release injectable suspension, Fast release injectable suspension), By Application (Hospital, Drug store), By Geographic Scope And Forecast

Exenatide Market Size And Forecast

Exenatide Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2022 to 2030.

During the forecasted period it is expected there will be growth in the market due to an increase in the number of middle-class households and increasing per capita income in countries along with this other important factors like technological advancement, the infrastructure of hospitals, and the availability of skilled medical are likely to play important roles in the growth of the market. The Global Exenatide Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Exenatide Market Definition

Diabetes mellitus type 2 is treated by the medication Exenatide which is marketed by Byetta, Bydureon. It is used along with other antidiabetic medication, diet, and exercise, it is a secondary treatment option after metformin and sulfonylureas. It is taken by injecting under the skin an hour before and after the last and first meaning of the day. Another version of this injection is also available which is once a week. A peptide that is like glucagon peptide – 1 receptor agonist (GLP-1 receptor agonist) is Exenatide. It decreases the excessive release of glycogen and increases the release of insulin from the pancreas.

It is also being checked for the treatment of Parkinson’s disease. A pen-like device Byetta is injected subcutaneously twice a day or once a week for this type of medication. The common injection site for this medication is the abdomen along with this it also has side effects diarrhea, indigestion, heartburn, nausea, and vomiting. Exenatide is not intended for people with gastrointestinal disease, it causes other side effects also headache, dizziness, and pancreatitis.

Global Exenatide Market Overview

The market is expected to see a considerable amount of growth during the forecast period. The increase is mainly attributed to the improved efficiency of GLP-1 (glucagon-like peptide-1). Increasing diabetes prevalence in established and emerging countries is expected to drive the market. The increase in the diabetic population over the years is due to the overall effect of individual-level factors, like the increasing median age of the population and health factors, including increasing rates of obesity and inactivity levels among people.

Moreover, lowering birth rates, along with increasing life expectancy, in countries like Japan, Italy, Germany, and France which have a high percentage of the geriatric population, are expected to drive the growth of the market. Furthermore, the growing health awareness among consumers and rising medical knowledge with the help of the internet are driving the sales of drugs.

However, the rise in the cost of treatment, advanced healthcare infrastructure, technological advancement, availability of skilled medical professionals, and side effects of the drugs are likely to hamper the growth of the Global Exenatide Market. The common side effects include low blood sugar, nausea, dizziness, abdominal pain, and pain at the site of injection. Other serious side effects may include medullary thyroid cancer, angioedema, pancreatitis, and kidney injury.

Global Exenatide Market Segmentation Analysis

The Global Exenatide Market is segmented on the basis of Type, Application, And Geography.

Exenatide Market, By Type

• Extended-release injectable suspension
• Fast release injectable suspension

Based on Type, The market is segmented into Extended-release injectable suspension and Fast release injectable suspension. Extended-release injectable is not the first recommended choice of medicine for the treatment of diabetes, due to its side effects like nausea and headache and fast release injectable suspension contributes more to the growth due to its lesser side effects as well as it helps the patient in lowering the body weight which is very important for the treatment of obese type 2 diabetes mellitus patient.

Exenatide Market, By Application

• Hospital
• Drug store

Based on Application, The market is segmented into Hospital and Drug store. The major contribution of this market is from the Drug store, as this type of medication is consumer-friendly and easy to use and consumers have to take it twice a day or once a week.

Exenatide Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Exenatide Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest contribution is expected from North America in the forecasted period due to the high per capita income of people in that region. However, the highest number of diabetic population is in China and India which are a part of the Asia Pacific region.

Key Players

The “Global Exenatide Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Teva pharmaceuticals Industries, Bachem AG, Ranbaxy laboratories limited. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• March 2022 – Teva Pharmaceuticals has signed an agreement with the Attorney general of Florida in this settlement Teva will provide life-saving medicine generic Narcan, it is a crucial step by Teva pharmaceuticals for life-saving treatments for people suffering from opioid addiction.
• April 2022 – DIAGNOS which is a leading corporation in the early detection of health issues by the use of AI has announced the extension of its contract with Novo Nordisk for diabetic patient treatment. Novo Nordisk therapeutic also has positive benefits like reducing the risk of retinopathy.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.